Login
Search Button
Button
Home
My NEI
CNS Spectrums
Store
About NEI
Search
Create Account
Search
View Cart
(0)
Log In
Membership
Membership Information
Sign Up or Renew
Overview
Rates
Groups and Institutions
Download Brochure
Member Benefits
Patient Education
Master Psychopharmacology Program
Stahl's Essential Psychopharmacology, Video Edition
Encore Presentations
NEI Prescribe
Become a Member
My NEI Portal
Meetings
NEI Meetings
Congress
Synapse
Saturday Morning Live
Practice Tools
Practice Tools
NEI Prescribe (Web Access)
NEI Prescribe (Download App)
Prescriber's Guide (PDFs)
Medication Tips and Pearls
Patient Education
Teaching Tools
Teaching Tools
Teaching Videos
Stahl's Essential Teaching Slides and Tests
NEI Teaching Slides
NEI Proctor: Master Psychopharmacology Program
Online CME/CE
By Format
Featured Activities
On Demand Videos
Cases
Articles
Animations
Self-Assessments (MOC)
Certificate Program
By Specialty
Primary Care
Pediatric
My NEI
Browsing articles in "Professional Improvement"
 
Highlights from 2023 NEI Congress: Scientific Poster Session Winners
November 10, 2023
The 2023 NEI Congress Scientific Poster Session was held on Friday, November 10th and featured 128 posters covering the full spectrum of mental health research and clinical data....
Continue reading
Suicide Risk Among Patients Hospitalized With Psychiatric Illness
October 26, 2023
Fifteen to thirty percent of patients with a history of concussion present with persistent postconcussion symptoms. Individuals with persistent postconcussion symptoms are at greater risk of developing depressive symptoms. In a recent meta-analysis of...
Continue reading
(Members only)
Meet DEA Training Requirements
October 16, 2023
Activities available as part of NEI Membership can fulfill the new, one-time eight-hour Drug Enforcement Administration requirement of the Medication Access and Training Expansion Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders . ....
Continue reading
Updates to DSM-5-TR Criteria and Text
September 13, 2023
The American Psychiatric Association (APA) released DSM-5-TR™ Update, a supplement to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). The supplement reflects approved updates to diagnostic criteria and related text, as well as...
Continue reading
(Members only)
CDC Estimates Suicides in U.S. Reached All-Time High in 2022
September 1, 2023
Provisional data released by the Center for Disease Control and Prevention (CDC) indicate that in 2022 there were 49,449 deaths from suicide in the United States. These data are quite disheartening especially given that deaths by suicide had declined in 2019 and 2020, only to rise by 5% in 2021; the provisional 2022 data represent a further 2.6% increase. When demographic data are evaluated, it can be seen that suicide death rates increased in...
Continue reading
World Schizophrenia Day: Education and Tool for Providers
May 24, 2023
The high rates of treatment resistance, relapse rates, and incidence of adverse effects in patients with schizophrenia suggest that a major treatment gap continues to still exist. Education is an essential tool in order for clinicians to integrate the new data, treatment options, and recommended management strategies into clinical practice as they become available...
Continue reading
2023 NEI Synapse: Biggest Mistakes in Psychopharm
April 2, 2023
On Saturday, April 1, we rounded out a fantastic 2023 NEI Synapse meeting with a special “Biggest Mistakes in Psychopharm” session. During this session, Drs. Manpreet Singh, Thomas Schwartz, and Andrew Cutler shared some of the common mistakes mental health care clinicians make in diagnosis and treatment of various mental health conditions and concerns...
Continue reading
FDA Approves First Over-the-Counter Naloxone Nasal Spray
March 29, 2023
The U.S. Food and Drug Administration approved naloxone hydrochloride nasal spray for over-the-counter, nonprescription, use. This overdose-reversing drug is the first opioid treatment drug to be sold over-the-counter. The approval of over-the-counter naloxone nasal spray will require...
Continue reading
The Future of Psychopharmacology
February 9, 2023
It is an incredible time in terms of the development of new psychopharmacological agents with novel mechanisms of action. In this article, leading experts in the field of psychopharmacology discuss the most promising medications in Phase II and III clinical trials that are being investigated for schizophrenia, bipolar disorder, major depressive disorder, anxiety, substance use disorders, and dementia...
Continue reading
(Members only)
Severe Mental Illness and Mass Murders in Academic Settings
December 6, 2022
Identifying consistent patterns among perpetrators of mass murders in academic settings, particularly by firearms, is critical for prevention efforts. Severe mental illness (SMI) is a hypothesized risk factor that has not been reliably predictive. A recent study compared mass shootings with mass murders by means other than firearms occurring in schools, colleges, and universities, while examining the relationship between...
Continue reading
1
2
3
4
5
6
7
8
9
10
...
Top of Page
Categories
All
Addiction/Reward
Additional Neurology Topics
ADHD
Alzheimer's/Other Dementias
Anxiety/Stress-Related Disorders
Basic Neuroscience
Bipolar Disorders
Brain Injuries
Child Psychiatry
Cognitive Disorders
Eating Disorders
Forensic Psychiatry
Geriatric Psychiatry
OCD
Pain
Personality Disorders
Pregnancy/Postpartum
Professional Improvement
Psychotic Disorders
Sexual Disorder
Side Effects
Sleep
Unipolar Depression